Clinical Trial: Efficacy and Safety of Millet Seed Extract in Telogen Effluvium Treatment
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Telogen Effluvium
Study Type: INTERVENTIONAL
Official Title: Efficacy and Safety of Millet Seed Extract in the Treatment of Telogen Effluvium in Female Patients: A Randomized, Double-Blind, Controlled Trial
Brief Summary:
This is a randomized, double-blind, controlled clinical trial investigating the efficacy and safety of millet seed extract capsules in treating telogen effluvium in female patients.The study will recruit 60 female participants with telogen effluvium who will be randomly assigned to receive either millet seed extract capsules (containing 420 mg millet seed extract, 200 mcg biotin, 6 mg L-cystine, and 27.48 mg vitamin B5) twice daily or Biotin forte capsules (5 mg biotin) once daily for 12 weeks.The primary outcome…
Read more